Cluster of differentiation 30, also TNFSF8, is a member of the TNR receptor superfamily. It is characteristically associated with anaplastic large cell lymphoma, and Hodgkin Lymphoma.
It is the target of brentuximab.
Cluster of differentiation 30, also TNFSF8, is a member of the TNR receptor superfamily. It is characteristically associated with anaplastic large cell lymphoma, and Hodgkin Lymphoma.
It is the target of brentuximab.